Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension. (2009)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/j.1476-5381.2009.00283.x

PubMed Identifier: 19508393

Publication URI: http://europepmc.org/abstract/MED/19508393

Type: Journal Article/Review

Volume: 157

Parent Publication: British journal of pharmacology

Issue: 7

ISSN: 0007-1188